Physician profile
Kataneh Maleki
NPI 1396706651
$10,020.40
in general payments reported to CMS, 2019-2025
37 companies · $939 in 2025
The $939 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,150 · 2020: $599 · 2021: $592 · 2022: $1,198 · 2023: $1,988 · 2024: $555 · 2025: $939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,530 · Travel and Lodging: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,530.33 |
| Travel and Lodging | $951.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,161.43 | 2019-2020 | |
| Medtronic, INC. | $1,942.29 | 2021-2025 | Micra, Selectsecure, Linq II |
| Boston Scientific Corporation | $1,864.91 | 2019-2024 | Watchman, Emblem Mri S-Icd, Watchman Access System |
| Abbott Laboratories | $858.83 | 2019-2025 | Jot Dx, Aveir |
| Biotronik INC. | $397.69 | 2019-2025 | Biomonitor, Acticor 7 Vr-T Dx |
| Biosense Webster, INC. | $340.16 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $271.61 | 2019-2025 | Camzyos, Eliquis, Empliciti |
| Janssen Pharmaceuticals, INC | $267.70 | 2019-2021 | |
| Cvrx, INC. | $252.96 | 2021-2025 | Barostim Neo System |
| Cardiva Medical, INC. | $208.26 | 2021-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $195.48 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $133.87 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $124.90 | 2024 | Optimizer |
| Zoll Respicardia, INC. | $118.71 | 2023 | Remede System |
| Edwards Lifesciences Corporation | $111.05 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $106.62 | 2022 | |
| Abiomed | $82.29 | 2023-2024 | Impella |
| Merck Sharp & Dohme LLC | $72.16 | 2021-2023 | Verquvo |
| Baxter Healthcare | $70.69 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $51.80 | 2023-2024 | |
| Shockwave Medical, INC | $47.03 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $43.13 | 2019-2020 | |
| Amgen INC. | $43.00 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $28.40 | 2022-2023 | Arcalyst |
| Atricure, INC. | $28.21 | 2022 | |
| Altathera Pharmaceuticals LLC | $23.76 | 2023 | Sotalol Hydrochloride |
| Renalytix Ai, INC. | $19.74 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Kestra Medical Technology Services, INC. | $17.82 | 2025 | Assure Wcd |
| Philips North America LLC | $17.51 | 2023 | |
| Tactile Systems Technology INC | $17.25 | 2023 | Flexitouch Plus, Entre Plus |
| Daiichi Sankyo INC. | $16.98 | 2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $16.29 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $14.97 | 2020 | |
| Avanos Medical | $14.22 | 2023 | Genvisc 850 Sodium Hyaluronate |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.06 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.54 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kataneh Maleki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.